Heidi secures $340M in equity and debt funding at $900M valuation
An Australian health-tech startup has closed a $100 million equity round, led by Blackbird, at a $900 million valuation. Separately, it arranged a $240 million growth investment facility from General Catalyst to fuel sales and marketing without diluting shareholders.
Sources: wsj.com
“The mix of equity and large nondilutive capital suggests confidence in scaling revenue, not just growth metrics—a shift from the burn-heavy playbook in health-tech.”
What it means
Health-tech valuations have faced scrutiny, but Heidi’s dual funding structure signals investor appetite for companies with clear paths to commercial traction. The $240 million facility’s terms aren’t public, but its size could pressure peers to pursue similar debt-like instruments rather than rely solely on venture rounds. Watch whether this becomes a template for later-stage health-tech startups.
Read the original reporting
The outlets below did the original reporting.
Related briefs
- Simple Energy’s $180M round drives India’s weekly funding surge
- Shionogi backs Celaid’s Series B, hinting at deeper biotech ties
- Snapdeal’s muted IPO raises questions about India’s ecommerce moats
- doxx.net raises $38M to build private networks for AI agents
- Airwallex-backed startup raises $50M seed in outlier round
This brief was drafted automatically from the sources above and published under our editorial policy. Spotted an error? Tell us.